Igraine Plc - Result of General Meeting and Board Changes
News provided by
Igraine Plc31 Oct, 2025, 16:09 GMT
31 October 2025
Igraine Plc
(“Igraine” or “the Company”)
Result of General Meeting and Board Changes
Igraine PLC is pleased to announce that at the Company's General Meeting held earlier today, all resolutions were duly passed.
Accordingly, all conditions precedent relating to the proposed placing and subscription (together the “Fundraise”) announced on 14 October 2025 have now been met.
As of the date of this announcement, £3,911,000 of the Fundraise monies have been received by the Company. The £3,240,000balance, consisting of funds raised via Subscription directly by the Company, have as yet not been received by the Company. The Board understands that these funds are in transit, but due primarily to issues with international bank transfers, receipt has been delayed. Therefore, at this stage application has been made only for the 1,564,400,000shares to be issued as a result of the placing successfully conducted by Peterhouse Capital Limited, Igraine’s Broker, and that part of the Subscription where funds have been received, to be admitted to trading on the Access segment of the Aquis Growth Market (the “First Admission”). It is expected that the First Admission shares will be admitted to trading on Tuesday, 4 November 2025. A further announcement will be made by the Company upon receipt of the remaining Subscription funds, at which time details of the resultant Second Admission will be provided.
The First Admission shares will, on Admission, rank pari passu in all respects with the Ordinary Shares and will rank in full for all dividends and other distributions hereafter declared, paid or made on the ordinary share capital of the Company.
As announced on 14 October 2025, following today’s General Meeting, Oliver Murphy has joined the Board and Simon Grant-Rennick has resigned as a director of the Company. The Board would like to thank Simon for his support and service over recent years. He has been instrumental in stabilising the Company and helping position it to be able to take advantage of opportunities such as those presented by this transaction. We wish Simon the best of luck in his future endeavours. The Board of the Company would also like to welcome Oliver Murphy to the Board.
Oliver Murphy is investing a total of £15,000 in the Fundraising, as further detailed below.
The proxy voting results of the resolutions are set out below:
| Resolution | For | Against | Discretion to Chairman | Percentage of Voting Rights | Withheld | Total |
| 01 | 93,546,700 | Nil | Nil | 77.15% | 272,545 | 93,819,245 |
| 02 | 93,546,700 | Nil | Nil | 77.15% | 272,545 | 93,819,245 |
| 03 | 93,476,700 | 70,000 | Nil | 77.15% | 272,545 | 93,819,245 |
| 04 | 93,546,700 | Nil | Nil | 77.15% | 272,545 | 93,819,245 |
| Total Voting Rights | 121,246,692 |
The change of name of the Company to EthTry Plc will be effective once Companies House has issued a certificate of incorporation on change of name and a further announcement will be made when the name is formally effective. The Company’s ticker will change to ETHY on Monday, 3 November 2025.
Following First Admission, the Company's issued share capital will comprise 1,685,646,692 Ordinary Shares, with each Ordinary Share carrying the right to one vote. Accordingly, the total number of voting rights in the Company will be 1,685,646,692 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the Circular to shareholders dated 16 October 2025.
Contacts
Company:
David Levis (Chief Executive Officer) info@igraineplc.com
AlbR Capital Limited (Aquis Corporate Adviser) +44 (0)20 7469 0930
Peterhouse Capital Ltd (Corporate Broker) +44 (0)20 7469 0930
| Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. | ||||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name |
|
||||
| 2 | Reason for the notification | |||||
| a) | Position/status |
|
||||
| b) | Initial notification /Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor | |||||
| a) | Name | Igraine PLC | ||||
| b) | LEI | 213800VX2NIA6TZN3139 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of nominal value £0.00002 each GB00BM9CKV18 | ||||
| b) | Nature of the transaction |
|
||||
| c) | Price(s) and volume(s) |
|
||||
| d) | Aggregated information - Aggregated volume - Price | 6,000,000 £0.0025 per share | ||||
| e) | Date of the transaction | 31 October 2025 | ||||
| f) | Place of the transaction | Direct Subscription | ||||
The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.
